Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4614-4626

  Verdaguer, Joan ^a   Amrani, Abdelaziz ^a   Anderson, Brad ^a   Schmidt, Dennis ^a   Santamaria, Pere ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CELL SPECIFICITY; DIABETOGENESIS; GENE TARGETING; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOID CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TARGET CELL;

AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CLONAL ANERGY; CLONAL DELETION; CROSSES, GENETIC; DIABETES MELLITUS, TYPE 1; FEMALE; GENES, T-CELL RECEPTOR BETA; IMMUNE TOLERANCE; IMMUNITY, NATURAL; INTERLEUKIN-4; ISLETS OF LANGERHANS; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, INBRED NOD; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033561752     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Delovitch, T. L., and B. Singh. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727.
2. Serreze, D. V., and E. H. Leiter. 1994. Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr. Opin. Immunol. 6:900.
3. 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43:500.
4. Vyse, T. J., and J. A. Todd. 1996. Genetic analysis of autoimmune disease. Cell 85:311.
5. Acha-Orbea, H., and H. O. McDevitt. 1987. The first external domain of the non-obese diabetic mouse class II I-Aβ chain is unique. Proc. Natl. Acad. Sci. USA 84:2435.
6. g7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156:450.
7. Kaufman, D., M. Clare-Salzler, J. Tian, T. Forsthuber, G. Ting, P. Robinson, M. Atkinson, E. Sercarz, A. Tobin, and P. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes mellitus. Nature 366:69.
8. Tisch, R., X. D. Yang, S. Singer, R. Liblau, L. Fugger, and H. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulins in nonobese diabetic mice. Nature 366:72.
9. Elliott, J., H. Quin, S. Bhatti, D. Smith, R. Singh, T. Dillon, J. Lauzon, and B. Singh. 1994. Immunization with the larger form of glutamic acid decarboxylase (GAD) prevents diabetes in NOD mice. Diabetes 43:1494.
10. Ridgway, W., M. Fasso, A. Lanctot, C. Garvey, and G. Fathman. 1996. Breaking self-tolerance in nonobese diabetic mice. J. Exp. Med. 183:1657.
11. Miller, J. F. A. P., and A Basten. 1996. Mechanisms of tolerance to self. Curr. Opin. Immunol. 8:815.
12. Ohashi, P., S. Oehen, K. Burki, H. Pircher, C. Ohashi, B. Odermatt, B. Malissen, R. Zinkernagel, and H. Hengartner. 1991. Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305.
13. Oldstone, M. B. A., M. Nerenberg, P. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319.
14. Ferber, I., G. Schönrich, J. Schenkel, A. Mellor, G. Hammerling, and B. Arnold. 1994. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 263:674.
15. Scott, B., R. Liblau, S. Degermann, L. Marconi, L. Ogata, A. Caton, H. McDevitt, and D. Lo. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73.
16. + T-cells is transient and depends on avidity. J. Immunol. 155:2339.
17. Von Herrath, M., S. Guerder, H. Lewicki, R. Flavell, and M. Oldstone. 1995. Coexpression of B7-1 and viral ("self") transgenes in pancreatic β cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 3:727.
18. + T cells specific for a pancreatic neoantigen. Immunity 2:573.
19. d in the liver. Eur. J. Immunol. 25:1932.
20. Katz, J. D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T-cell from genesis through pathogenesis. Cell 74:1089.
21. Lafaille, J., K. Nagashima, M. Katsuki, and S. Tonegawa. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78:399.
22. Kurrer, M. O., S. M. Pakala, H. Hanson, and J. D. Katz. 1997. β cell apoptosis in T-cell mediated autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94:213.
23. Schmidt, D., J. Verdaguer, N. Averill, and P. Santamaria. 1997. A mechanism for the major histocompalibility complex-linked resistance to autoimmunity. J. Exp. Med. 186:1059.
24. Verdaguer, J., D. Schmidt, A. Amrani, B. Anderson, N. Averill, and P. Santamaria. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186:1663.
25. Prochazka, M., D. Serreze, W. Franke, and E. Leiter. 1992. NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes 41:98.
26. Serreze, D. V., M. Prochazka, P. C. Reifsnyder, M. M. Bridgett, and E. H. Leiter. 1994. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J. Exp. Med. 180:1553.
27. + T-cells expressing identical endogenous TCRα chains. J. Immunol. 157:4726.
28. Yamada, K., N. Takane-Gyotoku, F. Ichikawa, C. Inada, and K. Nokada. 1996. Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 39: 1306.
29. Cameron, M. J., G. A. Arreaza, P. Zucker, S. W. Chensue, R. M. Strieter, S. Chakrabarti, and T. L. Delovitch. 1997. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J. Immunol. 159:4686.
30. Chervonsky, A., Y. Wang, F. Wong, I. Visintin, R. Flavell, C. A. Janeway, Jr., and L. Matis. 1997. The role of Fas in autoimmune diabetes. Cell 89:17.
31. Tian, J., M. Atkinson, M. Clare-Salzler, A. Herschenfeld, T. Forsthuber, P. Lehmann, and D. Kaufman. 1996. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1561.
32. Rapoport, M., A. Jaramillo, D. Zipris, A. Lazarus, D. Serreze, E. Leiter, P. Cyopick, J. Danska, and T. Delovitch. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:87.
33. Johns, L., K. Flanders, R. Ranges, and S. Sriram. 1991. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J. Immunol. 147:1792.
34. Abbas, A., K. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
35. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
36. Katz, J., C. Benoist, and D. Mathis. 1993. Major histocompatibility complex class I molecules are required for the generation of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23:3358.
37. Wicker, L., J. Todd, and L. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179.
38. null mice are diabetes and insulitis resistant. Diabetes 43:505.
39. + T-cells from nonobese diabetic mice use highly homologous T-cell receptor α-chain CDR3 sequences. J. Immunol. 154:2494.
40. Colucci, F., M. Bergman, C. Penha-Goncalves, C. Cilio, and D. Holmberg. 1997. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region Proc. Natl. Acad. Sci. USA 94:8670.
41. Ferner, P., J. C. Fontecilla-Camps, D. Bucchini, D. H. Caillol, B. R. Jordon, and F. A. Lemonnier. 1985. Altered structure of HLA class I heavy chains associated with mouse β-2 microglobulin. Immunogenetics 21:321.
42. d with human β-2 microglobulin induces localized conformational changes in the α-1 and -2 superdomain. Immunogenetics 30:361.
43. Danliczyk, U. G., and T. L. Delovitch. 1994. δ-2-microglobulin induces a conformational change in the MHC class I H chain that occurs intracellularly and is maintained at the cell surface. J. Immunol. 153:3533.
44. Serreze, D. V., M. Bridgett, H. D. Chapman, E. Chen, S. Richard, and E. H. Leiter. 1998. Subcongenic analysis of the Idd13 locus in NOD/Lt mice: evidence for several susceptibility genes including a possible diabetogenic role for β2-microglobulin. J. Immunol. 160:1472.
45. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16:34.
46. Alboran, I. D., J. A. Gonzalo, G. Kroemer, E. Leonardo, M. A. R. Marcos, and C. A. Martinez. 1992. Attenuation of autoimmune disease and lymphocyte accumulation in MRL/lpr mice by treatment with anti-Vβ8 antibodies. Eur. J. Immunol. 22:2153.
47. Zhou, S. R., and J. N. Whitaker. 1993. Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies. J. Immunol. 150:1629.
48. null mice. J. Exp. Med. 184:2049.
49. Boitard, C., R. Yasunami, M. Dardenne, and J.-F. Bach. 1989. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169:1669.
50. Reich, E. P., D. Scaringe, J. Yagi, R. S. Sherwin, and C. A. Janeway, Jr. 1989. Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes 38:1647.
51. + T cell clone, I. S. 2.15, has in vitro immunosuppressive properties. Eur. J. Immunol. 22:2017.
52. + T cell line. Diabetologia 36:716.
53. Utsugi, T., M. Nagata, T. Kawamura, and J.-W. Yoon. 1994. Prevention of recurrent diabetes in syngeneic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes. Transplantation 57:1799.
54. + β islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 182:87.
55. Lider, O., T. Reshef, E. Beraud, A. Ben-Nun, and I. R. Cohen. 1988. Antiidiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 239:181.
56. Lohse, A. W., F. Mor, N. Karin, and I. R. Cohen. 1989. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 244:820.
57. Vandenbark, A. A., G. Hashim, and H. Offner. 1989. Immunization with a synthetic T cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541.
58. Wilson, S., S. Kent, K. Patton, T. Orban, R. Jackson, M. Exley, S. Porcelli, D. Schatz, M. Atkinson, S. Balk, J. Strominger, and D. Hafler. 1998. Extreme Th1 bias of invariant Vα24JαQT cells in type 1 diabetes. Nature 391:177.
59. Santamaria, P., J. Barbosa, A. Lindstrom, T. Lemke, F. Goetz, and S. Rich. 1994. HLA-DQB1-associated susceptibility that distinguishes Hashimoto's thyroiditis from Graves' disease in type 1 diabetic patients. J. Clin. Endocrinol. Metab. 78:878.